share_log

Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement With Mexican Pharmaceutical Manufacturer For Initial Development And Production Of Its Mango Erectile Dysfunction Products

Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement With Mexican Pharmaceutical Manufacturer For Initial Development And Production Of Its Mango Erectile Dysfunction Products

Mangoceuticals子公司墨西哥MangorX與墨西哥製藥商簽署技術協議，初步開發和生產其芒果勃起功能障礙產品
Benzinga ·  04/12 20:46
Signifies the first major step towards the application process for the certification of itsMango ED oral dissolvable products by Mexico's health governing agency, COFEPRIS
標誌着朝着其認證申請程序邁出的重要第一步墨西哥衛生管理機構 COFEPRIS 出品的 Mango ED 口服可溶性產品
Dallas, Texas, April 12, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling a variety of men's health and wellness products in the area of erectile dysfunction (ED), hair growth and hormone replacement therapies is excited to announce that its subsidiary, MangoRx Mexico S.A. de C.V. ("MangoRx Mexico"), has secured and executed a technical agreement with Emifarma S.A. de C.V ("Emifarma") for...
得克薩斯州達拉斯，2024年4月12日（GLOBE NEWSWIRE）——專注於開發、營銷和銷售勃起功能障礙（ED）、頭髮生長和激素替代療法領域各種男...
登入免費觀看全文
登入/註冊

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論